COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
Besides the anticoagulant effect of LMWH, nonanticoagulant properties such as the reduction in interleukin 6 release have been shown to improve the complex picture of coagulopathy in patients with COVID-19.
1 min read